Meloxicam is an FDA approved COX-2 inhibiting nonsteroidal anti-inflammatory drug (NSAID). It reduces pain, stiffness and tenderness. The active pharmaceutical ingredient is indicated for
use in the treatment of osteoarthritis and rheumatoid arthritis.
Meloxicam is also used in the treatment of juvenile rheumatoid arthritis in children over two years of age. This drug is tolerated better than other NSAIDs and is a viable choice for patients who have difficulty talking other COX-2 inhibitors.
Pharmaceutica North America provides Meloxicam as a Bulk Active Pharmaceutical Ingredient (API). The purity and strength of API’s ensure that you are providing your patients with a stable,
safe medication of the highest standards.